**Question:** The following antagonises the visceral side effects of neostigmine used in reversal of d-TC blockade?

A. Atropine
B. Propranolol
C. Naloxone
D. Naloxone

**Core Concept:**
Neostigmine is a cholinesterase inhibitor that is used to reverse the effects of d-tubocurarine (d-TC), a muscle relaxant commonly used in anesthesia. The visceral side effects of neostigmine include gastrointestinal motility disturbances, increased salivation, and bronchoconstriction due to the stimulation of parasympathetic cholinergic receptors by neostigmine.

**Why the Correct Answer is Right:**
The correct answer is Atropine (A). Atropine is a competitive antagonist of the muscarinic acetylcholine receptors, specifically targeting the M1, M2, and M3 subtypes. These receptors are responsible for the visceral side effects of neostigmine due to their involvement in the parasympathetic cholinergic system. By blocking these receptors, atropine counteracts the effects of neostigmine and helps mitigate its side effects.

**Why Each Wrong Option is Incorrect:**

B. Propranolol (B): Propranolol is a beta-blocker used to treat hypertension and angina. While it can block beta-adrenergic receptors, it does not have any direct antagonistic effect on muscarinic acetylcholine receptors, making it an incorrect choice for counteracting the side effects of neostigmine.

C. Naloxone (C): Naloxone is a specific opioid antagonist that binds to opioid receptors and blocks their effects. Since neostigmine does not have opioid components, naloxone is irrelevant and therefore incorrect.

D. Naloxone (D): Similar to option C, naloxone does not have any effect on muscarinic acetylcholine receptors, making it an incorrect choice for counteracting the side effects of neostigmine.

**Clinical Pearl:**
In clinical practice, it is essential to recognize that the choice of antidote for neostigmine reversal depends on the specific clinical scenario. For example, if the patient has a history of asthma or heart disease, atropine may not be the preferred choice due to its potential to worsen bronchoconstriction and bradycardia, respectively. In such cases, a beta-agonist like salbutamol or isoprenaline might be more suitable. Always consider the patient's comorbidities and tailor your choice of antidote accordingly.